Tilray Brands, Inc. financial data

Symbol
TLRY on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
655 Madison Avenue, 19 Th Floor, New York, NY
Fiscal year end
May 31
Former names
Tilray, Inc. (to 1/10/2022)
Latest financial report
10-Q - Q3 2024 - Oct 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 203 % +19.5%
Quick Ratio 77 % +63.9%
Debt-to-equity 24.7 % -8.8%
Return On Equity -6.22 % +84.3%
Return On Assets -4.99 % +84%
Operating Margin -21.8 % +89.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 903M shares +23.7%
Common Stock, Shares, Outstanding 832M shares +15%
Entity Public Float 1.3B USD -45.8%
Common Stock, Value, Issued 88K USD +22.2%
Weighted Average Number of Shares Outstanding, Basic 875M shares +26.7%
Weighted Average Number of Shares Outstanding, Diluted 875M shares +26.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 812M USD +24.8%
Research and Development Expense 661K USD +11.1%
General and Administrative Expense 171M USD +3.5%
Operating Income (Loss) -177M USD +87.2%
Nonoperating Income (Expense) -20.8M USD +45.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -234M USD +83.7%
Income Tax Expense (Benefit) -33M USD -363%
Net Income (Loss) Attributable to Parent -213M USD +85.3%
Earnings Per Share, Basic -0.27 USD/shares +88.4%
Earnings Per Share, Diluted -0.27 USD/shares +88.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 205M USD +15.6%
Marketable Securities, Current 74.9M USD -73.9%
Accounts Receivable, after Allowance for Credit Loss, Current 104M USD +26.8%
Inventory, Net 264M USD +13.9%
Assets, Current 726M USD -12.5%
Other Long-term Investments 7.85M USD +3.82%
Property, Plant and Equipment, Net 555M USD +12.2%
Operating Lease, Right-of-Use Asset 17.2M USD +206%
Intangible Assets, Net (Excluding Goodwill) 909M USD -6.08%
Goodwill 2.01B USD +0%
Other Assets, Noncurrent 5.34M USD -38.3%
Assets 4.26B USD -3.19%
Accounts Payable, Current 102M USD +29%
Employee-related Liabilities, Current 10.3M USD +50.6%
Accrued Liabilities, Current 90.9M USD -29.8%
Liabilities, Current 294M USD -45.4%
Deferred Income Tax Liabilities, Net 136M USD -19.7%
Operating Lease, Liability, Noncurrent 16.9M USD
Other Liabilities, Noncurrent 99K USD +33.8%
Liabilities 778M USD -22.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -39.9M USD +8.46%
Retained Earnings (Accumulated Deficit) -2.7B USD -8.55%
Stockholders' Equity Attributable to Parent 3.48B USD +2.92%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.48B USD +2.41%
Liabilities and Equity 4.26B USD -3.19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.3M USD -123%
Net Cash Provided by (Used in) Financing Activities 60.6M USD +332%
Net Cash Provided by (Used in) Investing Activities -49.4M USD -87.9%
Common Stock, Shares Authorized 1.2B shares +22.2%
Common Stock, Shares, Issued 875M shares +21%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.2M USD +15.8%
Deferred Tax Assets, Valuation Allowance 790M USD +26.3%
Deferred Tax Assets, Gross 903M USD +26.2%
Operating Lease, Liability 21.4M USD +119%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -209M USD +85.2%
Lessee, Operating Lease, Liability, to be Paid 27M USD +47.4%
Property, Plant and Equipment, Gross 656M USD -9.78%
Operating Lease, Liability, Current 4.52M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.44M USD +56%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.09M USD +84.8%
Deferred Income Tax Expense (Benefit) 796K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.54M USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.54M USD +33.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4M USD +17.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 24.3M USD +970%
Depreciation, Depletion and Amortization 34.1M USD -13.4%
Deferred Tax Assets, Net of Valuation Allowance 114M USD +25.7%
Share-based Payment Arrangement, Expense 30.4M USD -21.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%